Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas

Figure 1 Screening flowchart for aggressive gastrointestinal non-Hodgkin lymphoma. NHL: Non-Hodgkin lymphoma; PGI: Primary gastrointestinal; GI: Gastrointestinal; MALT: Mucosal associated lymphoid tissue; FL: Follicular cell lymphoma; MCL: Mantle cell lymphoma; DLBCL: Diffuse large B-cell lymphoma; BL: Burkitt’s lymphoma; PGI-TNKL: Primary gastrointestinal T/NK cell lymphomas; ITCL: Intestinal T-cell lymphoma; ENKTCL: Extranodal natural killer T cell lymphoma.

Figure 2 Nomogram for predicting the risk of gastrointestinal complications in aggressive gastrointestinal non-Hodgkin lymphoma. GICs: Gastrointestinal complications; ITCL: Intestinal T-cell lymphoma; NK: Nature killer; DLBCL: Diffuse large B-cell lymphoma.

Figure 3 Decision curves analysis for the risk nomogram of gastrointestinal complications in aggressive gastrointestinal non-Hodgkin lymphoma.

Figure 4 The predictive performance of the risk nomogram for predicting gastrointestinal complications in aggressive gastrointestinal non-Hodgkin lymphoma. Receiver operating characteristic curves displayed that this nomogram discriminated well. AUC: Area under the curve.

Figure 5 The calibration curve of risk nomogram of gastrointestinal complications in aggressive gastrointestinal non-Hodgkin lymphoma. GICs: Gastrointestinal complications.

Figure 6 Survival analysis of the gastrointestinal complications and No-gastrointestinal complications groups in primary gastrointestinal non-Hodgkin lymphomas. A: Event-free survival curves for the comparison between gastrointestinal complications (GICs) and No-GICs group; B: Overall survival curves for the comparison between GICs and No-GICs group (P > 0.05). GICs: Gastrointestinal complications.